Pacific Biosciences
PACB
HK$12.09
Share price
-6.10%
Change (1 day)
-24.53%
Change (1 year)
Categories
Pacific Biosciences (PACB) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : HK$6.03 Billion
According to Pacific Biosciences 's latest financial reports the company's total liabilities are HK$6.03 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Pacific Biosciences - Total liabilities on balance sheet (from 2009 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | HK$5.85 B | -28.27% |
| 2023-12-31 | HK$8.15 B | -13.28% |
| 2022-12-31 | HK$9.40 B | -0.77% |
| 2021-12-31 | HK$9.48 B | 1458.31% |
| 2020-12-31 | HK$0.60 B | -16.05% |
| 2019-12-31 | HK$0.72 B | 64.66% |
| 2018-12-31 | HK$0.44 B | -2.82% |
| 2017-12-31 | HK$0.45 B | 9.77% |
| 2016-12-31 | HK$0.41 B | -7.51% |
| 2015-12-31 | HK$0.44 B | -17.16% |
| 2014-12-31 | HK$0.53 B | 3.66% |
| 2013-12-31 | HK$0.51 B | 230.19% |
| 2012-12-31 | HK$0.15 B | -24.55% |
| 2011-12-31 | HK$0.20 B | 3.55% |
| 2010-12-31 | HK$0.20 B | -90.66% |
| 2009-12-31 | HK$2.15 B | 35.19% |
| 2008-12-31 | HK$1.59 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | HK$29.93 B | 395.87% | 🇺🇸 USA |
 NanoString Technologies NSTG | HK$2.55 B | -57.71% | 🇺🇸 USA |
 General Electric GE | HK$821.46 B | 13,506.56% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | HK$388.97 B | 6,342.95% | 🇺🇸 USA |
 PerkinElmer
PKI | HK$51.83 B | 758.65% | 🇺🇸 USA |